Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000625809 | SCV000746366 | likely pathogenic | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 2017-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001529466 | SCV002205905 | uncertain significance | not provided | 2025-01-08 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 603 of the COL4A1 protein (p.Pro603Ser). This variant is present in population databases (rs747585517, gnomAD 0.002%). This missense change has been observed in individual(s) with multi-cystic dysplastic kidney (PMID: 31230195). ClinVar contains an entry for this variant (Variation ID: 522668). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt COL4A1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005004277 | SCV005632426 | uncertain significance | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome; Brain small vessel disease 1 with or without ocular anomalies; Hemorrhage, intracerebral, susceptibility to; Retinal arterial tortuosity; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529466 | SCV001742977 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529466 | SCV001808406 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Yale Center for Mendelian Genomics, |
RCV001849420 | SCV002106634 | likely pathogenic | Congenital anomaly of kidney and urinary tract | 2019-06-22 | no assertion criteria provided | literature only |